Skip to content

Climb Bio, Inc. CLYM Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Rumble, Inc. logo
Rumble, Inc.RUM
-$337.78K-40.4%
Mission Produce, Inc. logo
Mission Produce, Inc.AVO
-$2.8M-3.7%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4.74M-16.2%
NextNav logo
NextNavNN
$77K-63.7%
Target Hospitality logo
Target HospitalityTH
-$2.3M-33.9%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s short- and long-term operating lease liabilities?
Climb Bio, Inc. (CLYM) reported short- and long-term operating lease liabilities of -$62K in Q1 2026.
How has Climb Bio, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
Climb Bio, Inc.'s short- and long-term operating lease liabilities decreased by 5.1% year-over-year, from -$59K to -$62K.
What is the long-term trend for Climb Bio, Inc.'s short- and long-term operating lease liabilities?
Over 3 years (2022 to 2025), Climb Bio, Inc.'s short- and long-term operating lease liabilities has grown at a -54.2% compound annual growth rate (CAGR), from -$447K to $43K.